Clinical Trial

Visual Field Analysis With Artificial Intelligence

Study acronym: VFAAI
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to analyze visual field data from healthy participants. This data will be used to develop and optimize a new visual field perimeter test. The test will incorporate an advanced algorithm, which may include the use of Artificial Intelligence (AI), to enhance accuracy and efficiency in identifying test points.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-02.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-10-30
Trial Details
NCT Number NCT06920290
Lead Sponsor Sight Intelligence Engineering Corporation
Conditions Glaucoma, Visual Field Defect
Enrollment 100 participants
Start Date 2025-07-01
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-03